I graduated with a Bachelor of Pharmacy in March, 2013 from the East West University, Dhaka, Bangladesh. In October, 2013; I started my Master Degree M.Sc in Molecular Diagnostics and Biotechnology at the University of Camerino, MC, Italy. During my master I went to Aarhus University, Denmark and spent several months on research works under ERASMUS+ mobility for study and traineeship program. That was a great opportunity to work with several other groups from Germany and Norway. I did all experimental works and wrote my master thesis at Aarhus.
After completing my master degree in February, 2016; I have experienced with a Post-graduate traineeship at Kyoto University, Kyoto, Japan.
Summary of ESR Project
Non-alcoholic fatty liver disease (NAFLD) affects 20-30% of the general population, over 100 million people in the US and in Europe, at epidemic proportions. These figures point to a daunting disease burden closely related to obesity. A pressing unmet medical need has been identified to develop robust biomarkers and powerful drugs, so that effective medical care may be targeted to those patients that will benefit most. This project will benefit from the generation of non-invasive advanced biomarkers across a histologically characterized Portuguese NAFLD cohort, so that new findings can then used in meaningful reverse translation medicine using animal models of NAFLD. Using data from previous phenotypic drug screening, this project will also accelerate drug development, so that new treatments may be effectively translated and delivered in the clinic.
Dr. Cecilia Rodrigues
Dr. Rui Castro
French National Institute of Health and Medical Research (INSERM), France
Dr. Carina Prip-Buus
Dr. Andrea Normann